Asian Market’s Top Value Stock Picks For April 2025

editorial-team@simplywallst.com (Simply Wall St)

Tue, Apr 1, 2025, 12:07 AM 4 min read

As global markets grapple with economic uncertainty and inflation concerns, the Asian stock markets have shown resilience, presenting opportunities for value investors. In this environment, identifying undervalued stocks becomes crucial as they may offer potential for growth amidst cautious optimism and market volatility.

Click here to see the full list of 276 stocks from our Undervalued Asian Stocks Based On Cash Flows screener.

Here’s a peek at a few of the choices from the screener.

Overview: Consun Pharmaceutical Group Limited is engaged in the research, development, manufacturing, and sale of Chinese medicines and medical contrast medium products in the People’s Republic of China with a market cap of HK$7.68 billion.

Operations: The company’s revenue is derived from the Consun Pharmaceutical Segment, contributing CN¥2.53 billion, and the Yulin Pharmaceutical Segment, adding CN¥442.84 million.

Estimated Discount To Fair Value: 47.7%

Consun Pharmaceutical Group appears undervalued, trading at HK$9.24, significantly below its estimated fair value of HK$17.66. Recent earnings growth of 16.1% and expected annual profit growth of 13% surpass the Hong Kong market’s average, indicating strong operational performance. The company reported increased sales and net income for 2024, alongside a proposed dividend of HK$0.3 per share. However, it has an unstable dividend track record despite its robust cash flow potential and promising product developments like the SK-08 Tablet for CKD treatment.

• In light of our recent growth report, it seems possible that Consun Pharmaceutical Group’s financial performance will exceed current levels.

• Dive into the specifics of Consun Pharmaceutical Group here with our thorough financial health report.

Overview: iFAST Corporation Ltd. operates as a provider of investment products and services across Singapore, Hong Kong, Malaysia, China, and the United Kingdom with a market capitalization of SGD2.21 billion.